Dr. Athiya Agarwal has filed a prior intimation regarding the acquisition of 14,41,568 shares (0.46%) of Dr. Agarwal’s Health Care Limited from Dr. Anosh Agarwal. This transaction, scheduled for March 13, 2026, is structured as an inter-se transfer (gift) between immediate relatives within the Promoter Group. Consequently, there will be no change in the total shareholding of the Promoter and Promoter Group following the gift.
Prior Intimation of Share Acquisition
Dr. Athiya Agarwal has submitted a formal disclosure concerning the proposed acquisition of equity shares in Dr. Agarwal’s Health Care Limited (the Target Company). The acquisition involves 14,41,568 shares, representing 0.46% of the total share capital. The proposed date for this transfer is set as March 13, 2026.
Transaction Details: Inter-se Gift Transfer
The transaction involves a transfer of shares from Dr. Anosh Agarwal to Dr. Athiya Agarwal. Both parties are identified as existing Promoters of the Target Company. The rationale for the transfer is explicitly stated as an inter-se transfer amongst immediate relatives by way of gift. As the transfer is a gift, the acquisition price is determined as NIL, with no consideration involved.
Exemption Rationale
This acquisition falls under the exemption provided by Regulation 10(1)(a)(i) of the relevant SEBI regulations concerning inter-se transfers among immediate relatives. The filer confirms that the proposed acquisition is part of a private transfer family arrangement aimed at streamlining the family’s assets and businesses.
Shareholding Post-Transaction
A critical aspect of this disclosure is that the transaction will result in no change in the aggregate shareholding of the Promoter and Promoter Group. The shareholding details before and after the proposed transaction confirm this:
- Dr. Athiya Agarwal (Acquirer): Her holding increases from 1,26,61,975 shares (4.00%) to 1,41,03,543 shares (4.45%).
- Dr. Anosh Agarwal (Seller): His holding decreases from 1,48,57,920 shares (4.69%) to 1,34,16,352 shares (4.23%).
The acquirer, Dr. Athiya Agarwal, has also provided a declaration confirming compliance with all applicable disclosure requirements concerning the transferor and transferee.
Source: BSE
